Christina T Muijs

Has grant

Associate professor

University Medical Center Groningen
Country flagNetherlands

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Models project; developing prediction models for complications after neo-adjuvant chemoradiotherapy and resection

Open Date: 2023-02-01

Close Date:

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Purpose: To present results from the trial radiotherapy quality assurance (RTQA) programme of the centres involved in the randomised phase-III PROton versus photon Therapy for esophageal Cancer – a Trimodality strategy (PROTECT)-trial, investigating the clinical effect of proton therapy (PT) vs. photon therapy (XT) for patients with oesophageal cancer. Materials and methods: The pre-trial RTQA programme consists of benchmark target and organ at risk (OAR) delineations as well as treatment planning cases, a facility questionnaire and beam output audits. Continuous on-trial RTQA with individual case review (ICR) of the first two patients and every fifth patient at each participating site is performed. Patient-specific QA is mandatory for all patients. On-site visits are scheduled after the inclusion of the first two patients at two associated PT and XT sites. Workshops are arranged annually for all PROTECT participants. Results: Fifteen PT/XT sites are enrolled in the trial RTQA programme. Of these, eight PT/XT sites have completed the entire pre-trial RTQA programme. Three sites are actively including patients in the trial. On-trial ICR was performed for 22 patients. For the delineation of targets and OARs, six major and 11 minor variations were reported, and for six patients, there were no remarks. One major and four minor variations were reported for the treatment plans. Three site visits and two annual workshops were completed. Interpretation: A comprehensive RTQA programme was implemented for the PROTECT phase III trial. All centres adhered to guidelines for pre-trial QA. For on-trial QA, major variations were primarily seen for target delineations (< 30%), and no treatment plans required re-optimisation.

Year:

2025

Year:

2025

Purpose Medical imaging is crucial in modern radiotherapy, aiding diagnosis, treatment planning, and monitoring. The development of synthetic imaging techniques, particularly synthetic computed tomography (sCT), continues to attract interest in radiotherapy. The SynthRAD2025 dataset and the accompanying SynthRAD2025 Grand Challenge aim to stimulate advancements in synthetic CT generation algorithms by providing a platform for comprehensive evaluation and benchmarking of synthetic CT generation algorithms based on cone‐beam CTs (CBCT) and magnetic resonance images (MRI). Acquisition and validation methods The dataset comprises 2362 cases, including 890 MRI‐CT pairs and 1472 CBCT‐CT pairs of head‐and‐neck, thoracic, and abdominal cancer patients treated at five European university medical centers [UMC Groningen, UMC Utrecht, Radboud UMC (Netherlands), LMU University Hospital Munich, and University Hospital of Cologne (Germany)]. Images were acquired using a wide range of acquisition protocols and scanners. Pre‐processing, including rigid and deformable image registration methods, was performed to ensure high‐quality image datasets and alignment between modalities. Extensive quality assurance was performed to validate image consistency and usability. Data format and usage notes All imaging data is provided using the MetaImage (.mha) file format, ensuring compatibility with common medical image processing tools. Metadata, including acquisition parameters and registration details, is available in structured comma‐separated value (CSV) files. To ensure dataset integrity, SynthRAD2025 is split into training (65%), validation (10%), and test (25%) sets. The dataset is accessible through https://doi.org/10.5281/zenodo.14918088 under the SynthRAD2025 collection. Potential applications This dataset enables benchmarking and development of synthetic imaging techniques for radiotherapy applications. Potential use cases include sCT generation for MRI‐only and MR‐guided photon and proton radiotherapy, CBCT‐based dose calculations, and adaptive radiotherapy workflows. By incorporating data from diverse acquisition settings, SynthRAD2025 supports the advancement of robust and generalizable image synthesis algorithms for clinical implementation, ultimately promoting personalized cancer care and improving adaptive radiotherapy workflows.

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

Elke Van Daele

Ghent University Hospital

BELGIUM
View details

Lisanne van Dijk

Associate professor & Technical physician

University Medical Center Groningen

NETHERLANDS
View details

Arturs Meijers

Head of clinical medical physics

Paul Scherrer Institut

SWITZERLAND
View details

Niklas Wahl

Research Group Leader

Deutsches Krebsforschungszentrum

GERMANY
View details

Matthias Guckenberger

Chairman

University Hospital of Zurich

SWITZERLAND
View details

Nanna Maria Sijtsema

University Medical Center Groningen

NETHERLANDS
View details

Hanneke W. M. van Laarhoven

-

NETHERLANDS
View details

John H. Maduro

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Hanna Rahbek Mortensen

Associate Professor

Aarhus University

DENMARK
View details

Alessio Giuseppe Morganti

ALMA MATER STUDIORUM UNIVERSITY OF BOLOGNA

ITALY
View details

Jacco de Haan

University Medical Center Groningen

NETHERLANDS
View details

Camiel Rosman

Radboud University Medical Center

NETHERLANDS
View details

Erik Korevaar

University Medical Center Groningen

NETHERLANDS
View details

Johannes A. Langendijk

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Ditte Sloth Møller

Head of Medical Physics

Aarhus University

DENMARK
View details

Arjen van der Schaaf

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

L. Hoffmann

VIP, Associate Professor

Aarhus University Hospital

DENMARK
View details

Anna Dorothea Wagner

Senior lecturer, consultant and head of the gastrointestinal cancer outpatient clinic

Lausanne University Hospital

SWITZERLAND
View details

Per Pfeiffer

University of Southern Denmark

DENMARK
View details